Healthcare provider profile · identity verified

Veronica Mcfarlane, APNP

Nurse Practitioner · MANITOWOC, WI · NPI 1063809499

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	554	142
Omeprazole	Omeprazole	276	62
Amlodipine Besylate	Amlodipine Besylate	271	67
Lisinopril	Lisinopril	266	68
Losartan Potassium	Losartan Potassium	261	70
Simvastatin	Simvastatin	250	58
Levothyroxine Sodium	Levothyroxine Sodium	229	58
Metoprolol Succinate	Metoprolol Succinate	186	45
Hydrochlorothiazide	Hydrochlorothiazide	157	41
Sertraline Hcl	Sertraline Hcl	148	33
Albuterol Sulfate Hfa	Albuterol Sulfate	142	47
Potassium Chloride	Potassium Chloride	131	34
Alendronate Sodium	Alendronate Sodium	123	42
Metformin Hcl Er	Metformin Hcl	121	33
Furosemide	Furosemide	119	36
Gabapentin	Gabapentin	109	30
Metformin Hcl	Metformin Hcl	101	23
Rosuvastatin Calcium	Rosuvastatin Calcium	97	22
Glipizide Er	Glipizide	91	21
Bupropion Xl	Bupropion Hcl	90	19
Escitalopram Oxalate	Escitalopram Oxalate	89	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	22
Metoprolol Tartrate	Metoprolol Tartrate	79	22
Pravastatin Sodium	Pravastatin Sodium	76	23
Ezetimibe	Ezetimibe	74	20
Trulicity	Dulaglutide	71	12
Tamsulosin Hcl	Tamsulosin Hcl	66	19
Fluoxetine Hcl	Fluoxetine Hcl	60	suppressed
Xarelto	Rivaroxaban	59	suppressed
Fluticasone Propionate	Fluticasone Propionate	56	16
Meloxicam	Meloxicam	56	17
Pantoprazole Sodium	Pantoprazole Sodium	56	18
Eliquis	Apixaban	55	12
Atenolol	Atenolol	52	16
Duloxetine Hcl	Duloxetine Hcl	47	suppressed
Buspirone Hcl	Buspirone Hcl	46	11
Allopurinol	Allopurinol	45	12
Raloxifene Hcl	Raloxifene Hcl	45	12
Warfarin Sodium	Warfarin Sodium	45	12
Famotidine	Famotidine	43	12
Spironolactone	Spironolactone	42	13
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Ozempic	Semaglutide	38	suppressed
Incruse Ellipta	Umeclidinium Bromide	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	17
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Nystatin	Nystatin	32	17
Lorazepam	Lorazepam	31	suppressed
Arnuity Ellipta	Fluticasone Furoate	30	suppressed
Digoxin	Digoxin	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Diazepam	Diazepam	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Finasteride	Finasteride	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Estradiol	Estradiol	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Prednisone	Prednisone	13	suppressed
Carvedilol	Carvedilol	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Methimazole	Methimazole	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Temazepam	Temazepam	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error